GC Biopharma's Breakthrough Anthrax Vaccine BARYTHRAX Shows Promising Safety and Efficacy GC Biopharma announces successful Phase 2 data for BARYTHRAX, the world's first recombinant anthrax vaccine, showcasing safety and strong immune response.

GC Biopharma's Breakthrough Anthrax Vaccine BARYTHRAX Shows Promising Safety and Efficacy #South_Korea #GC_Biopharma #Yongin #BARYTHRAX #Anthrax_Vaccine

GC Biopharma Pioneers Anthrax Vaccine Approval, Sets New Safety Standards GC Biopharma's innovative anthrax vaccine, BARYTHRAX, gains approval in South Korea, marking a breakthrough in vaccine safety and efficacy.

GC Biopharma Pioneers Anthrax Vaccine Approval, Sets New Safety Standards #South_Korea #GC_Biopharma #Yongin #BARYTHRAX #Anthrax_Vaccine